AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
May 4, 2011
30016_dirs_2011-05-04_6413a149-f80e-40d2-8a15-70edaa01c813.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-05-03
Reporting Person: NAQUI ALI (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-03 | Common Stock | M | 7922 | $28.655 | Acquired | 26842 | Direct |
| 2011-05-03 | Common Stock | S | 7000 | $80.5438 | Disposed | 19842 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-03 | Non-Qualified Stock Option (right to buy) | $28.655 | M | 7922 | Acquired | 2015-02-02 | Common Stock (7922) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $80.50 to $80.75, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy shares of common stock becomes exercisable as to 2,320 shares on 02/03/2006, 02/03/2007 and 02/03/2008, and the remaining 962 shares on 02/03/2009.